帕金森病和认知障碍患者的血GPNMB水平增加
Xuelin Qi1,2, Zonghan She1,2, Xiaoxue Shi1,2,3
1Department of Neurology, Zhengzhou University People's Hospital, No.7, Wei Wu Road, Jinshui District, Zhengzhou City, 450003, Henan Province, China.
Scientific reports
|July 2, 2025
概括
葡萄糖蛋白非转移性黑色素瘤蛋白B (GPNMB) 的血水平与帕金森病 (PD) 的认知衰退和大脑变化相关. 升高的GPNMB与记忆力缺陷和左骨灰质体积减少有关.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 医疗成像医学成像
背景情况:
- 糖蛋白非转移性黑色素瘤蛋白B (GPNMB) 是一种I型跨膜蛋白.
- GPNMB成熟成一种可溶性形式,这表明在细胞外信号传递中具有潜在的作用.
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是运动和非运动症状,包括认知障碍.
研究的目的:
- 为了研究血GPNMB水平和帕金森病 (PD) 患者的临床表现之间的关联.
- 通过神经成像来探索血GPNMB水平和PD中的大脑结构变化之间的关系.
- 确定GPNMB作为PD进展和相关病理学的潜在生物标志物.
主要方法:
- 在PD患者和健康对照中,使用酶相关免疫吸收试验 (ELISA) 量化了血GPNMB水平.
- 用蒙特利尔认知评估 (MoCA) 尺度评估认知功能,重点关注与记忆相关的子项目.
- 基于voxel的形态测量 (VBM) 用于分析灰色物质体积变化,以左侧晶状核作为感兴趣的区域.
主要成果:
- 血GPNMB水平与PD相关的认知障碍有显著的相关性.
- 较高的GPNMB水平与评估延迟记忆的MoCA子项目表现较差有关.
- 观察到血GPNMB水平与左骨灰质体积之间存在中度负相关性.
结论:
- 血GPNMB水平是帕金森病中认知功能障碍的潜在指标.
- 左侧门可能是受GPNMB影响的关键大脑区域,在PD病理学中.
- 这项研究为GPNMB在PD的临床和成像特征中的作用提供了新的见解.
相关概念视频
01:24Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
01:37Neural Regulation
40.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.3K
01:15Parkinson's Disease: Overview
718
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
718